PSYCHOTROPIC MEDICATION USE IN ADULTS WITH INTELLECTUAL DISABILITY IN QUEENSLAND, AUSTRALIA FROM 1999 TO 2016

被引：0
|
作者：
Song, M. [1 ]
Harley, D. [1 ]
Ware, R. [2 ]
Doan, T. [3 ]
机构：
[1] Univ Queensland, Mater Res Inst, Queensland Ctr Intellectual & Dev Disabil, Brisbane, Qld, Australia
[2] Menzies Hlth Inst Queensland, Southport, Qld, Australia
[3] Univ Melbourne, Dept Med, Melbourne, Vic, Australia
来源：
JOURNAL OF INTELLECTUAL DISABILITY RESEARCH | 2019年 / 63卷 / 07期
关键词：
psychotropic medication; challenging behaviour; intellectual disability; cohort;
D O I：
暂无
中图分类号：
G76 [特殊教育];
学科分类号：
040109 ;
摘要：
引用
收藏
页码：691 / 691
页数：1
相关论文
共 50 条
  • [31] PSYCHOTROPIC-DRUG USE IN PEOPLE WITH AN INTELLECTUAL DISABILITY
    RYAN, MG
    EPILEPSIA, 1995, 36 : S167 - S168
  • [32] The use of medication to manage behaviour problems in adults with an intellectual disability: a national guideline
    Unwin, Gemma L.
    Deb, Shoumitro
    ADVANCES IN MENTAL HEALTH AND INTELLECTUAL DISABILITIES, 2010, 4 (03) : 4 - 11
  • [33] Chemical restraint of adults with intellectual disability and challenging behaviour in Queensland, Australia: Views of statutory decision makers
    Edwards, Nicole
    King, Julie
    Williams, Karen
    Hair, Sara
    JOURNAL OF INTELLECTUAL DISABILITIES, 2020, 24 (02) : 194 - 211
  • [34] Symposium: Psychotropic Medication Use in People With Intellectual Disabilities
    Courtenay, Ken
    JOURNAL OF MENTAL HEALTH RESEARCH IN INTELLECTUAL DISABILITIES, 2017, 10 : 192 - 192
  • [35] The Pharmacoepidemiology of Psychotropic Medication Use in Canadian Children from 2012 to 2016
    Pringsheim, Tamara
    Stewart, David G.
    Chan, Parco
    Tehrani, Ali
    Patten, Scott B.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2019, 29 (10) : 740 - 745
  • [36] THE PHARMACOEPIDEMIOLOGY OF PSYCHOTROPIC MEDICATION USE IN CANADIAN CHILDREN FROM 2012 TO 2016
    Pringsheim, Tamara
    Stewart, David G.
    Chan, Parco
    Tehrani, Ali
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2018, 57 (10): : S162 - S162
  • [37] Determinants of psychotropic medication in adults with mild or moderate intellectual disabilities
    Schuetzwohl, M.
    Voss, E.
    Stiawa, M.
    Salize, H. -J.
    Puschner, B.
    Koch, A.
    NERVENARZT, 2017, 88 (11): : 1273 - 1280
  • [38] QUALITY OF PSYCHOTROPIC MEDICATION TREATMENT IN ADULTS WITH INTELLECTUAL DISABILITIES IN GERMANY
    Koch, A.
    Dobrindt, J.
    Schuetzwohl, M.
    JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, 2019, 63 (07) : 697 - 697
  • [39] PREVALENCE OF PSYCHOTROPIC MEDICATION TREATMENT IN ADULTS WITH INTELLECTUAL DISABILITIES IN GERMANY
    Dobrindt, J.
    Koch, A.
    Schuetzwohl, M.
    JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, 2019, 63 (07) : 696 - 696
  • [40] Management of psychotropic medications in adults with intellectual disability: a scoping review
    Costello, Ashley
    Hudson, Eithne
    Morrissey, Susan
    Sharma, Drona
    Kelly, Dervla
    Doody, Owen
    ANNALS OF MEDICINE, 2022, 54 (01) : 2486 - 2499
12345